Welcome to visit Zhongnan Medical Journal Press Series journal website!

Analysis of risk factors of central venous catheter-related bloodstream infection

Published on Apr. 29, 2024Total Views: 205 timesTotal Downloads: 421 timesDownloadMobile

Author: TANG Chunyan LUO Dan CHEN Qian LI Wei

Affiliation: Department of Intensive Care, The People's Hospital of Jianyang City, Jianyang 641400, Sichuan Province, China

Keywords: Central vein placement Catheter-related bloodstream infection Risk factors Receiver operating characteristic curve

DOI: 10.12173/j.issn.1004-5511.202310099

Reference: Tang CY, Luo D, Chen Q, Li W. Analysis of risk factors of central venous catheter-related bloodstream infection[J]. Yixue Xinzhi Zazhi, 2024, 34(4): 417-423. DOI: 10.12173/j.issn.1004-5511.202310099.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To explore the risk factors for the development of central venous catheter-related bloodstream infections (CRBSI).

Methods  The clinical data of patients undergoing central venous catheterization in The People’s Hospital of Jianyang City from February 2019 to February 2023 were retrospective and analyzed, and they were divided into CRBSI group and non-CRBSI group. Basic data of the two groups were compared. The risk factors for CRBSI were determined by multivariate Logistic regression analysis. A predictive model for CRBSI patient was construsted through receiver operating characteristic curves (ROC).

Results  A total of 304 patients were included, including 47 (15.46%) in the CRBSI group and 257 (84.54%) in the non-CRBSI group. The age, BMI, and APACHE Ⅱ score in the CRBSI group were significantly higher than the non-CRBSI group, and the catheterization time was significantly longer than the non-CRBSI group. The proportion of diabetes mellitus, ICU site, internal jugular vein or femoral vein were significantly higher than that in the non-CRBSI group, and the differences were statistically significant (P<0.05). Multifactor Logistic analysis indicated that older age [OR=3.067, 95%CI (1.238, 7.598)], high BMI [OR=1.894, 95%CI (1.215, 2.952)], coexistence of diabetes [OR=1.609, 95%CI (1.129, 2.293)], high APACHE II score [OR=2.287, 95%CI (1.174, 4.455)], catheterization location in the ICU [OR=4.106, 95%CI (1.600, 10.537)], catheterization site being the internal jugular or femoral vein [OR=3.416, 95%CI (1.583, 7.371)], and prolonged catheterization duration [OR=1.416, 95%CI (1.019, 1.968)] were risk factors for CRBSI in patients. According to ROC analysis, age, BMI, APACHE Ⅱ score, catheterization time and multivariate Logistic regression model were all used for the prediction of CRBSI in patients with central venous catheterization, and the multivariate Logistic regression model can obtain higher area under the curve [AUC=0.981, 95%CI(0.967, 0.996)], sensitivity(0.957) and specificity(0.961).

Conclusion  The occurrence of CRBSI  in patients with central venous catheters is influenced by factors such as age, BMI, APACHE II score, catheterization site, catheterization site location, and duration of catheterization. It is important to consider these factors comprehensively, to take timely and appropriate intervention measures, and to prevent as early as possible in clinical practice.

Full-text
Please download the PDF version to read the full text: download
References

1.Safety Committee of Japanese Society of Anesthesiologists. Practical guide for safe central venous catheterization and management 2017[J]. J Anesth, 2020, 34(2): 167-186. DOI: 10.1007/s00540-019-02702-9.

2.谢朝云, 蒙桂鸾, 熊芸, 等. 中心静脉导管相关性血流感染预后相关因素分析[J]. 中国医学科学院学报, 2020, 42(6): 789-794. [Xie CY, Meng GL, Xiong Y, et al. Prognostic factors of central venous catheter-related bloodstream infections[J]. Acta Academiae Medicinae Sinicae, 2020, 42(6): 789-794.] DOI: 10.3881/j.issn.1000-503X.12266.

3.袁本林. MHD患者发生CRBSI的病原菌、耐药情况及影响因素分析[J]. 医学临床研究, 2020, 37(7): 1023-1025, 1029. [Yuan BL. Analysis of pathogenic bacteria, drug resistance and influencing factors of CRBSI in MHD patients[J]. Journal of Clinical Research, 2020, 37(7): 1023-1025, 1029.] DOI: 10.3969/j.issn.1671-7171.2020.07.020.

4.Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update[J]. Infect Control Hosp Epidemiol, 2014, 35(7): 753-71. DOI: 10.1086/676533.

5.Yokota PK, Marra AR, Belucci TR, et al. Outcomes and predictive factors associated with adequacy of antimicrobial therapy in patients with central line-associated bloodstream infection[J]. Front Public Health, 2016, 4(26): 284-284. DOI: 10.3389/fpubh.2016.00284.

6.Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009, 49(1): 1-45. DOI: 10.1086/599376.

7.刘卫珍 ,罗丽, 熊楚梅. 急性生理学及慢性健康状况评分系统Ⅱ在重症监护病房护理中的应用[J]. 护理研究, 2010, 24(1): 9-11. [Liu WZ, Luo L, Xiong CM. Application of APACHE Ⅱ scoring in nursing care of patients in intensive care unit[J]. Chinese Nursing Research, 2010, 24(1): 9-11.] DOI: 10.3969/j.issn.1009-6493.2010.01.004.

8.孙锦霞, 张旭珍. 三甲医院血透中心静脉CRBSI病原菌特征分布、耐药性调查及相关防控对策研究[J]. 中国中西医结合肾病杂志, 2021, 22(12): 1100-1102. [Sun JX, Zhang XZ. Investigation of pathogenic bacteria characteristic distribution, drug resistance and related prevention and control measures of CRBSI in central venous hemodialysis hospitals[J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2021, 22(12):1100-1102.] DOI: 10.3969/j.issn.1009-587X.2021.12.024.

9.韩娜, 孟宪静. 肺癌患者外周静脉置入中心静脉导管并发相关性血流感染的独立危险因素分析[J]. 中国医刊, 2020, 55(9): 1042-1044. [Han N, Meng XJ. Independent risk factors analysis of peripheral venous catheters in patients with lung cancer complicated by associated bloodstream infection[J]. Chinese Journal of Medicine, 2020, 55(9): 1042-1044.] DOI: 10.3969/j.issn.1008-1070.2020.09.037.

10.李道新, 熊飞, 李红兵,等. 血液透析患者导管相关性血流感染的危险因素及其预测模型构建[J]. 中华医院感染学杂志, 2023, 33(3): 368-371. [Li DX, Xiong F, Li HB, et al. Risk factors of catheter-related bloodstream infection in hemodialysis patients and construction of prediction model[J]. Chinese Journal of Nosocomiology, 2023, 33(3): 368-371.] DOI: 10.11816/cn.ni.2023-213313.

11.袁榕, 黄霞红, 吴丹阳. 个体化预测重症监护室中心静脉导管相关性血流感染预警模型的建立[J]. 中国消毒学杂志, 2022, 39(2): 128-131. [Yuan R, Huang XH, Wu DY. Establishment on an early warning model for individualized prediction of associated blood flow infection ICU central venous catheter[J]. Chinese Journal of Disinfection, 2022, 39(2): 128-131.] https://www.nstl.gov.cn/paper_detail.html?id=aa6b624423460c041e37e9d500fd497d.

12.李中瑞, 李静, 郑蕊,等. 重症监护病房血管内导管相关血流感染调查[J]. 中华医院感染学杂志, 2019, 29(5): 658-660, 664. [Li ZR, Li J, Zheng R, et al. Prevalence of intravascular catheter-related bloodstream infections in intensive care unit[J]. Chinese Journal of Nosocomiology, 2019, 29(5): 658-660, 664.] DOI: 10.11816/cn.ni.2019-180551.

13.曾勇, 李小英, 蒋秋萍,等. 严重烧伤病人血流感染的流行病学特点及死亡危险因素分析[J]. 医学动物防制, 2019, 35(10): 927-931. [Zeng Y, Li XY, Jiang QP, et al. Study of the epidemiological characteristics of bloodstream infection and risk factors of death in patients with severe burns[J]. Journal of Medical Pest Control, 2019, 35(10): 927-931.] DOI: 10.7629/yxdwfz201910003.

14.叶晓燕, 金彩香, 韩智云. 中心静脉导管相关性血流感染的危险因素与预防研究[J]. 中华医院感染学杂志, 2015, 25(9): 2157-2160. [Ye XY, Jin CX, Han ZY. Risk factors for central venous catheter-associated bloodstream infections and study on prevention[J]. Chinese Journal of Nosocomiology, 2015, 25(9): 2157-2160.] DOI: 10.11816/cn.ni.2015-134331.

15.陈丽娟, 刘丽红, 孙林利,等. 预防烧伤患者中心静脉导管相关性血流感染的范围综述[J]. 中华烧伤杂志, 2021, 37(10): 970-977. [Chen LJ, Liu LH, Sun LL, et al. Scoping review on prevention of central venous catheter-related bloodstream infection in burn patients[J]. Chinese Journal of Burns and Wounds, 2021, 37(10): 970-977.] DOI: 10.3760/cma.j.cn501120-20201027-00447.

16.朱其荣, 陈星, 喻雪琴, 等. 血液透析患者血管内导管相关血流感染病原菌的流行病学特征及耐药性评估分析[J]. 川北医学院学报, 2019, 34(2): 201-204. [Zhu QR, Chen X, Yu XQ, et al. Epidemiological characteristics of distribution of pathogenic bacteria in catheter-related bloodstream infection in hemodialysis patients and drug resistance evaluation analysis[J]. Journal of North Sichuan Medical College, 2019, 34(2): 201-204.] DOI: 10.3969/j.issn.1005-3697.2019.02.10.

17.蒙绪标, 刘婷婷, 符兰芳,等. 2型糖尿病患者体液免疫、细胞免疫变化与胰岛素敏感性的相关性分析[J]. 长春中医药大学学报, 2021, 37(5): 1076-1079.[Meng XB, Liu TT, Fu LF, et al. An investigation on the correlation between the changes of humoral and cellular immunity and insulin sensitivity in patients with type 2 diabetes[J]. Journal of Changchun University of Chinese Medicine, 2021, 37(5): 1076-1079.] DOI: 10.13463/j.cnki.cczyy.2021.05.033.

18.戴凡, 吴传芳, 谭创, 等. 血管导管相关血流感染预防与控制最佳证据实施现状调查[J]. 中国感染控制杂志, 2022, 21(8): 774-780. [Dai F, Wu CF, Tan C, et al. Implementation situation of best evidence practice for prevention and control of vascular catheter-related bloodstream infection[J]. Chinese Journal of Infection Control, 2022, 21(8): 774-780.] DOI: 10.12138/j.issn. 1671-9638.20222673.

19.张政, 徐一鹏, 伍万. 导管相关性血流感染的临床特点及病死率回顾性分析[J]. 中国医药, 2022, 17(8): 1216-1220. [Zhang Z, Xu YP, Wu W. Retrospective analysis of clinical characteristics and mortality of catheter-related bloodstream infection[J]. China Medicine, 2022, 17(8): 1216-1220.] DOI: 10.3760/j.issn.1673-4777.2022.08.022.

20.豆欣蔓, 谢琪, 张丽红,等. 经隧道式中心静脉导管行血液透析导管相关血流感染发病率及危险因素的系统评价与Meta分析[J]. 中国血液净化, 2023, 22(3): 214-220. [Dou XM, Xie Q, Zhang LH, et al. Incidence and risk factors for catheter-related bloodstream infections in hemodialysis through tunneled central venous catheters:a systematic review and Meta-analysis[J]. Chinese Journal of Blood Purification, 2023, 22(3): 214-220.] DOI: 10.3969/j.issn.1671-4091.2023.03.013.

21.陈丽娟, 刘丽红, 孙林利, 等. 预防烧伤患者中心静脉导管相关性血流感染的范围综述[J]. 中华烧伤杂志, 2021, 37(10): 970-977. [Chen LJ, Liu LH, Sun LL, et al. Scoping review on prevention of central venous catheter-related bloodstream infection in burn patients[J]. Chinese Journal of Burns and Wounds, 2021, 37(10):970-977.] DOI: 10.3760/cma.j.cn501120-20201027-00447.